Français

Scientific and Medical Advisory Council

The Scientific and Medical Advisory Council (SMAC) provides strategic advice to Crohn’s and Colitis Canada on scientific and medical matters relevant to the organization’s mission. The SMAC advises on medical and scientific policy and program issues, ensuring Crohn’s and Colitis Canada’s work is evidence-based and reflects the best science. Read the SMAC Terms of Reference here. 

Icons representing the Scientific and Medical Advisory council (SMAC)

SMAC members:

 
Members Title
Laura Sly, PhD 
(co-Chair, Basic)		 Professor of Medicine
University of British Columbia
Frank Hoentjen, MD, PhD 
(co-Chair, Clinical)		 Professor  of Medicine, Director - IBD Unit
Division of Gastroenterology
University of Alberta
Deanna Gibson, PhD 
(Past Chair)		 Professor, University of British Columbia, Okanagan Campus
Colette Deslandres, MD  Head of Gastroenterology Division & Professor of Medicine
Inflammatory Bowel Disease Program Director
CHU Sainte-Justine 
Université de Montréal
Simon Hirota, PhD Professor, University of Calgary
Ellen Kuenzig, PhD Assistant Professor, Western University
Emma Allen-Vercoe, PhD Professor, Canada Research Chair, Department of Molecular and Cellular Biology, University of Guelph
Marcel Behr, MD, MSc Professor of Medicine, McGill University
David Armstrong, MD, FRCPC Professor of Medicine, McMaster University & Hamilton Health Sciences
Laurence Chapuy, MD, PhD Clinician-scientist, Pediatric gastroenterologist, Assistant professor, CHU Sainte-Justine, Université de Montréal
Karen Wong, MD, FRCPC Associate Professor, University of Alberta

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.

Other Areas of Interest

Gutsy Walk
Go Here
Volunteer